Drug uptake transporters in antiretroviral therapy

Pharmacology and Therapeutics

Volumn 132, Issue 3, 2011, Pages 268-279

  Minuesa, Gerard ^a   Huber Ruano, Isabel ^b   Pastor Anglada, Marçal ^b   Koepsell, Hermann ^c   Clotet, Bonaventura ^a   Martinez Picado, Javier ^a,d  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Antiretroviral drugs; Drug disposition; Drug transporters; Human immunodeficiency virus (HIV); Immune cells; SLC superfamily

Indexed keywords

ABACAVIR; ACICLOVIR; ADEFOVIR; AMPRENAVIR; ANTIVIRUS AGENT; ATAZANAVIR; CIDOFOVIR; CYTIDINE; DARUNAVIR; DIDANOSINE; EFAVIRENZ; EMTRICITABINE; FOSAMPRENAVIR; GANCICLOVIR; INDINAVIR; LAMIVUDINE; LOPINAVIR; MARAVIROC; NELFINAVIR; NEVIRAPINE; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 2; RALTEGRAVIR; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR; TIPRANAVIR; ZALCITABINE; ZIDOVUDINE;

ANTIVIRAL THERAPY; AREA UNDER THE CURVE; ARTICLE; BINDING AFFINITY; BONE MARROW SUPPRESSION; CAPILLARY ENDOTHELIUM; CARDIOMYOPATHY; CD4+ T LYMPHOCYTE; CELL TRANSPORT; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG BINDING SITE; DRUG DISPOSITION; DRUG EFFICACY; DRUG ELIMINATION; DRUG METABOLISM; DRUG PENETRATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG TOLERABILITY; DRUG UPTAKE; FATTY LIVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IC 50; KIDNEY TUBULE CELL; LACTIC ACIDOSIS; MACROPHAGE; MITOCHONDRIAL TOXICITY; MONOCYTE; MUSCLE HYPERTROPHY; PANCREATITIS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TREATMENT RESPONSE; VIRUS REPLICATION;

EID: 80054995643     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.06.007     Document Type: Review

References (126)

1. M. Alebouyeh, M. Takeda, M.L. Onozato, A. Tojo, R. Noshiro, and H. Hasannejad Expression of human organic anion transporters in the choroid plexus and their interactions with neurotransmitter metabolites J Pharmacol Sci 93 2003 430 436 (Pubitemid 38195311)
2. P.L. Anderson, T.N. Kakuda, and K.A. Lichtenstein The cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities Clin Infect Dis 38 2004 743 753 (Pubitemid 38333873)
3. P. Annaert, Z.W. Ye, B. Stieger, and P. Augustijns Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1 Xenobiotica 40 2010 163 176
4. A. Antinori, G. Arendt, J.T. Becker, B.J. Brew, D.A. Byrd, and M. Cherner Updated research nosology for HIV-associated neurocognitive disorders Neurology 69 2007 1789 1799 (Pubitemid 350059308)
5. D.J. Back, D.M. Burger, C.W. Flexner, and J.G. Gerber The pharmacology of antiretroviral nucleoside and nucleotide reverse transcriptase inhibitors: implications for once-daily dosing J Acquir Immune Defic Syndr 39 Suppl. 1 2005 [S1-23, quiz S24-25]
6. S.A. Baldwin, S.Y. Yao, R.J. Hyde, A.M. Ng, S. Foppolo, and K. Barnes Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes J Biol Chem 280 2005 15880 15887 (Pubitemid 40616710)
7. C. Bazzoli, V. Jullien, C. Le Tiec, E. Rey, F. Mentre, and A.M. Taburet Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action Clin Pharmacokinet 49 2010 17 45
8. K. Bleasby, J.C. Castle, C.J. Roberts, C. Cheng, W.J. Bailey, and J.F. Sina Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition Xenobiotica 36 2006 963 988 (Pubitemid 44844110)
9. D.K. Blumenthal, and J.C. Garrison Pharmacodynamics: molecular mechanisms of drug action L.L. Brunton, B.A. Chabner, B.C. Knollman, Googman Gilman's The pharmacological basis of therapeutics 2010 McGraw-Hill Professional New York City, NY 41 72
10. I.L.O. Buxton, and L.Z. Benet Pharmacokinetics: the dynamics of drug absorption, distribution, metabolism and elimination L.L. Brunton, B.A. Chabner, B.C. Knollman, Googman Gilman's The pharmacological basis of therapeutics 2010 McGraw-Hill Professional New York City, NY 17 40
11. Cano-Soldado, P., Pastor-Anglada, M., (in press). Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition. Med Res Rev, Feb 1 doi: 10.1002/med.20221 Epub ahead of print.
12. P. Cano-Soldado, I.M. Lorrayoz, M. Molina-Arcas, F.J. Casado, J. Martinez-Picado, and M.P. Lostao Interaction of nucleoside inhibitors of HIV-1 reverse transcriptase with the concentrative nucleoside transporter-1 (SLC28A1) Antivir Ther 9 2004 993 1002 (Pubitemid 40040273)
13. A. Carr Toxicity of antiretroviral therapy and implications for drug development Nat Rev Drug Discov 2 2003 624 634 (Pubitemid 37361766)
14. C. Chang, P.W. Swaan, L.Y. Ngo, P.Y. Lum, S.D. Patil, and J.D. Unadkat Molecular requirements of the human nucleoside transporters hCNT1, hCNT2, and hENT1 Mol Pharmacol 65 2004 558 570 (Pubitemid 38264023)
15. Y. Chen, S. Li, C. Brown, S. Cheatham, R.A. Castro, and M.K. Leabman Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin Pharmacogenet Genomics 19 2009 497 504
16. T. Cihlar, D.C. Lin, J.B. Pritchard, M.D. Fuller, D.B. Mendel, and D.H. Sweet The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1 Mol Pharmacol 56 1999 570 580 (Pubitemid 29406884)
17. T. Cihlar, E.S. Ho, D.C. Lin, and A.S. Mulato Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs Nucleosides Nucleotides Nucleic Acids 20 2001 641 648 (Pubitemid 32821831)
18. J.M. Coffin HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy Science 267 1995 483 489
19. C.D. Cropp, T. Komori, J.E. Shima, T.J. Urban, S.W. Yee, and S.S. More Organic anion transporter 2 (SLC22A7) is a facilitative transporter of cGMP Mol Pharmacol 73 2008 1151 1158 (Pubitemid 351439197)
20. M. Cvetkovic, B. Leake, M.F. Fromm, G.R. Wilkinson, and R.B. Kim OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine Drug Metab Dispos 27 1999 866 871 (Pubitemid 29347585)
21. V.E. Demby, K.A. Harmon, M. Naqwe, J.E. Humphreys, M. Wire, and J.W. Polli OATP1B1, OATP1B3 and BCRP transporter characterization for fosamprenavir, amprenavir and lopinavir AAPS Annual Meeting and Exposition (AAPS) 2008 http://www.aapsj.org/abstracts/AM-2008/AAPS2008-002355.PDF [Abstract #2355]
22. P. Domingo, J. Torres-Torronteras, V. Pomar, M. Giralt, J.C. Domingo, and M. Gutierrez Mdel Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome PLoS One 5 2010 e13896
23. S. Duflot, M. Calvo, F.J. Casado, C. Enrich, and M. Pastor-Anglada Concentrative nucleoside transporter (rCNT1) is targeted to the apical membrane through the hepatic transcytotic pathway Exp Cell Res 281 2002 77 85 (Pubitemid 35373784)
24. E. Errasti-Murugarren, and M. Pastor-Anglada Drug transporter pharmacogenetics in nucleoside-based therapies Pharmacogenomics 11 2010 809 841
25. E. Errasti-Murugarren, M. Pastor-Anglada, and F.J. Casado Role of CNT3 in the transepithelial flux of nucleosides and nucleoside-derived drugs J Physiol 582 2007 1249 1260 (Pubitemid 47104352)
26. E. Errasti-Murugarren, P. Cano-Soldado, M. Pastor-Anglada, and F.J. Casado Functional characterization of a nucleoside-derived drug transporter variant (hCNT3C602R) showing altered sodium-binding capacity Mol Pharmacol 73 2008 379 386 (Pubitemid 351159208)
27. E. Errasti-Murugarren, P. Diaz, V. Godoy, G. Riquelme, and M. Pastor-Anglada Expression and distribution of nucleoside transporter in the human syncytiotrophoblast Mol Pharmacol 2011 Aug 8. (Epub ahead of print)
28. S. Eyal, P. Hsiao, and J.D. Unadkat Drug interactions at the blood-brain barrier: fact or fantasy? Pharmacol Ther 123 2009 80 104
29. S. Fernandez-Veledo, R. Valdes, V. Wallenius, F.J. Casado, and M. Pastor-Anglada Up-regulation of the high-affinity pyrimidine-preferring nucleoside transporter concentrative nucleoside transporter 1 by tumor necrosis factor-alpha and interleukin-6 in liver parenchymal cells J Hepatol 41 2004 538 544 (Pubitemid 39297787)
30. C. Fork, T. Bauer, S. Golz, A. Geerts, J. Weiland, and D. Del Turco OAT2 catalyses efflux of glutamate and uptake of orotic acid Biochem J 436 2011 305 312
31. Y. Fukuchi, T. Furihata, M. Hashizume, M. Iikura, and K. Chiba Characterization of ribavirin uptake systems in human hepatocytes J Hepatol 52 2010 486 492
32. K.M. Giacomini, S.M. Huang, D.J. Tweedie, L.Z. Benet, K.L. Brouwer, and X. Chu Membrane transporters in drug development Nat Rev Drug Discov 9 2010 215 236
33. J.E. Gibbs, and S.A. Thomas The distribution of the anti-HIV drug, 2'3'-dideoxycytidine (ddC), across the blood-brain and blood-cerebrospinal fluid barriers and the influence of organic anion transport inhibitors J Neurochem 80 2002 392 404 (Pubitemid 36383023)
34. H. Glaeser, D.G. Bailey, G.K. Dresser, J.C. Gregor, U.I. Schwarz, and J.S. McGrath Intestinal drug transporter expression and the impact of grapefruit juice in humans Clin Pharmacol Ther 81 2007 362 370 (Pubitemid 46364477)
35. R. Govindarajan, A.H. Bakken, K.L. Hudkins, Y. Lai, F.J. Casado, and M. Pastor-Anglada In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta Am J Physiol Regul Integr Comp Physiol 293 2007 R1809 R1822
36. R. Govindarajan, C.J. Endres, D. Whittington, E. LeCluyse, M. Pastor-Anglada, and C.M. Tse Expression and hepatobiliary transport characteristics of the concentrative and equilibrative nucleoside transporters in sandwich-cultured human hepatocytes Am J Physiol Gastrointest Liver Physiol 295 2008 G570 G580
37. R. Govindarajan, G.P. Leung, M. Zhou, C.M. Tse, J. Wang, and J.D. Unadkat Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3 Am J Physiol Gastrointest Liver Physiol 296 2009 G910 G922
38. J.P. Guallar, P. Cano-Soldado, I. Aymerich, J.C. Domingo, M. Alegre, and P. Domingo Altered expression of nucleoside transporter genes (SLC28 and SLC29) in adipose tissue from HIV-1-infected patients Antivir Ther 12 2007 853 863 (Pubitemid 47492555)
39. B. Hagenbuch, and C. Gui Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family Xenobiotica 38 2008 778 801
40. B. Hagenbuch, and P.J. Meier Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties Pflugers Arch 447 2004 653 665 (Pubitemid 38241451)
41. H. Han, R.L. de Vrueh, J.K. Rhie, K.M. Covitz, P.L. Smith, and C.P. Lee 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter Pharm Res 15 1998 1154 1159 (Pubitemid 28401703)
42. R.C. Hartkoorn, W.S. Kwan, V. Shallcross, A. Chaikan, N. Liptrott, and D. Egan HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms Pharmacogenet Genomics 20 2010 112 120
43. L. He, K. Vasiliou, and D.W. Nebert Analysis and update of the human solute carrier (SLC) gene superfamily Hum Genomics 3 2009 195 206
44. S.E. Hesselson, P. Matsson, J.E. Shima, H. Fukushima, S.W. Yee, and Y. Kobayashi Genetic variation in the proximal promoter of ABC and SLC superfamilies: liver and kidney specific expression and promoter activity predict variation PLoS One 4 2009 e6942
45. R.H. Ho, and R.B. Kim Transporters and drug therapy: implications for drug disposition and disease Clin Pharmacol Ther 78 2005 260 277 (Pubitemid 41254111)
46. H. Hu, C.J. Endres, C. Chang, N.S. Umapathy, E.W. Lee, and Y.J. Fei Electrophysiological characterization and modeling of the structure activity relationship of the human concentrative nucleoside transporter 3 (hCNT3) Mol Pharmacol 69 2006 1542 1553
47. T. Imaoka, H. Kusuhara, M. Adachi, J.D. Schuetz, K. Takeuchi, and Y. Sugiyama Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir Mol Pharmacol 71 2007 619 627 (Pubitemid 46147926)
48. O. Janneh, A. Owen, B. Chandler, R.C. Hartkoorn, C.A. Hart, and P.G. Bray Modulation of the intracellular accumulation of saquinavir in peripheral blood mononuclear cells by inhibitors of MRP1, MRP2, P-gp and BCRP AIDS 19 2005 2097 2102 (Pubitemid 41668997)
49. O. Janneh, R.C. Hartkoorn, E. Jones, A. Owen, S.A. Ward, and R. Davey Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir Br J Pharmacol 155 2008 875 883
50. O. Janneh, T. Anwar, C. Jungbauer, S. Kopp, S.H. Khoo, and D.J. Back P-glycoprotein, multidrug resistance-associated proteins and human organic anion transporting polypeptide influence the intracellular accumulation of atazanavir Antivir Ther 14 2009 965 974
51. O. Janneh, B. Chandler, R. Hartkoorn, W.S. Kwan, C. Jenkinson, and S. Evans Intracellular accumulation of efavirenz and nevirapine is independent of P-glycoprotein activity in cultured CD4 T cells and primary human lymphocytes J Antimicrob Chemother 64 2009 1002 1007
52. S.M. Jarvis, J.A. Thorn, and P. Glue Ribavirin uptake by human erythrocytes and the involvement of nitrobenzylthioinosine-sensitive (es)-nucleoside transporters Br J Pharmacol 123 1998 1587 1592 (Pubitemid 28182042)
53. N. Jung, and D. Taubert Organic cation transporters and their roles in antiretroviral drug disposition Expert Opin Drug Metab Toxicol 5 2009 773 787
54. N. Jung, C. Lehmann, A. Rubbert, M. Knispel, P. Hartmann, and J. van Lunzen Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection Drug Metab Dispos 36 2008 1616 1623
55. N. Kimura, S. Masuda, Y. Tanihara, H. Ueo, M. Okuda, and T. Katsura Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1 Drug Metab Pharmacokinet 20 2005 379 386
56. O. Kis, K. Robillard, G.N. Chan, and R. Bendayan The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters Trends Pharmacol Sci 31 2010 22 35
57. O. Kis, J.A. Zastre, M. Ramaswamy, and R. Bendayan pH dependence of organic anion-transporting polypeptide 2B1 in Caco-2 cells: potential role in antiretroviral drug oral bioavailability and drug-drug interactions J Pharmacol Exp Ther 334 2010 1009 1022
58. D. Kobayashi, T. Nozawa, K. Imai, J. Nezu, A. Tsuji, and I. Tamai Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane J Pharmacol Exp Ther 306 2003 703 708 (Pubitemid 36886171)
59. K. Kock, M. Grube, G. Jedlitschky, L. Oevermann, W. Siegmund, and C.A. Ritter Expression of adenosine triphosphate-binding cassette (ABC) drug transporters in peripheral blood cells: relevance for physiology and pharmacotherapy Clin Pharmacokinet 46 2007 449 470 (Pubitemid 46827856)
60. H. Koepsell, K. Lips, and C. Volk Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications Pharm Res 24 2007 1227 1251 (Pubitemid 46876495)
61. S. Kramer-Hammerle, I. Rothenaigner, H. Wolff, J.E. Bell, and R. Brack-Werner Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus Virus Res 111 2005 194 213 (Pubitemid 40909736)
62. G.A. Kullak-Ublick, M.G. Ismair, B. Stieger, L. Landmann, R. Huber, and F. Pizzagalli Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver Gastroenterology 120 2001 525 533 (Pubitemid 32147650)
63. Y. Lai, C.M. Tse, and J.D. Unadkat Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs J Biol Chem 279 2004 4490 4497 (Pubitemid 38199039)
64. M.K. Leabman, C.C. Huang, J. DeYoung, E.J. Carlson, T.R. Taylor, and M. de la Cruz Natural variation in human membrane transporter genes reveals evolutionary and functional constraints Proc Natl Acad Sci USA 100 2003 5896 5901 (Pubitemid 36576904)
65. H. Lee, J. Hanes, and K.A. Johnson Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase Biochemistry 42 2003 14711 14719 (Pubitemid 37553499)
66. E.W. Lee, Y. Lai, H. Zhang, and J.D. Unadkat Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for interspecies differences in mitochondrial toxicity of fialuridine J Biol Chem 281 2006 16700 16706
67. J.A. Levy HIV pathogenesis: 25 years of progress and persistent challenges AIDS 23 2009 147 160
68. W. Lewis Mitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questions Antiviral Res 58 2003 189 197 (Pubitemid 36589009)
69. W. Lewis, and M.C. Dalakas Mitochondrial toxicity of antiviral drugs Nat Med 1 1995 417 422
70. A.C. Lockhart, R.G. Tirona, and R.B. Kim Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy Mol Cancer Ther 2 2003 685 698
71. H. Lu, and C. Klaassen Tissue distribution and thyroid hormone regulation of Pept1 and Pept2 mRNA in rodents Peptides 27 2006 850 857
72. J.R. Mackey, S.Y. Yao, K.M. Smith, E. Karpinski, S.A. Baldwin, and C.E. Cass Gemcitabine transport in xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters J Natl Cancer Inst 91 1999 1876 1881
73. W.B. Mahony, B.A. Domin, S.M. Daluge, and T.P. Zimmerman Membrane permeation characteristics of abacavir in human erythrocytes and human T-lymphoblastoid CD4+ CEM cells: comparison with (-)-carbovir Biochem Pharmacol 68 2004 1797 1805 (Pubitemid 39278502)
74. M.P. McRae, C.M. Lowe, X. Tian, D.L. Bourdet, R.H. Ho, and B.F. Leake Ritonavir, saquinavir, and efavirenz, but not nevirapine, inhibit bile acid transport in human and rat hepatocytes J Pharmacol Exp Ther 318 2006 1068 1075 (Pubitemid 44268312)
75. P.J. Meier, and B. Stieger Bile salt transporters Annu Rev Physiol 64 2002 635 661 (Pubitemid 34259244)
76. G. Minuesa, S. Purcet, I. Erkizia, M. Molina-Arcas, M. Bofill, and N. Izquierdo-Useros Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells J Pharmacol Exp Ther 324 2008 558 567 (Pubitemid 351185862)
77. G. Minuesa, C. Volk, M. Molina-Arcas, V. Gorboulev, I. Erkizia, and P. Arndt Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3 J Pharmacol Exp Ther 329 2009 252 261
78. L.J. Montaner, S.M. Crowe, S. Aquaro, C.F. Perno, M. Stevenson, and R.G. Collman Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs J Leukoc Biol 80 2006 961 964 (Pubitemid 44646301)
79. D.M. Moss, W.S. Kwan, N.J. Liptrott, D.L. Smith, M. Siccardi, and S.H. Khoo Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir Antimicrob Agents Chemother 55 2010 879 887
80. J. Muller, K.S. Lips, L. Metzner, R.H. Neubert, H. Koepsell, and M. Brandsch Drug specificity and intestinal membrane localization of human organic cation transporters (OCT) Biochem Pharmacol 70 2005 1851 1860 (Pubitemid 41612016)
81. M.A. Nagle, D.M. Truong, A.V. Dnyanmote, S.Y. Ahn, S.A. Eraly, and W. Wu Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling J Biol Chem 286 2011 243 251
82. T. Nakatani-Freshwater, and D.R. Taft Renal excretion of emtricitabine II. effect of trimethoprim on emtricitabine excretion: In vitro and in vivo studies J Pharm Sci 97 2008 5411 5420
83. T. Nakatani-Freshwater, and D.R. Taft Renal excretion of emtricitabine I: effects of organic anion, organic cation, and nucleoside transport inhibitors on emtricitabine excretion J Pharm Sci 97 2008 5401 5410
84. H. Ogihara, H. Saito, B.C. Shin, T. Terado, S. Takenoshita, and Y. Nagamachi Immuno-localization of H+/peptide cotransporter in rat digestive tract Biochem Biophys Res Commun 220 1996 848 852 (Pubitemid 26198600)
85. M. Pastor-Anglada, P. Cano-Soldado, M. Molina-Arcas, M.P. Lostao, I. Larrayoz, and J. Martinez-Picado Cell entry and export of nucleoside analogues Virus Res 107 2005 151 164 (Pubitemid 40093088)
86. M. Pastor-Anglada, P. Cano-Soldado, E. Errasti-Murugarren, and F.J. Casado SLC28 genes and concentrative nucleoside transporter (CNT) proteins Xenobiotica 38 2008 972 994
87. S.D. Patil, L.Y. Ngo, P. Glue, and J.D. Unadkat Intestinal absorption of ribavirin is preferentially mediated by the Na+-nucleoside purine (N1) transporter Pharm Res 15 1998 950 952 (Pubitemid 28307840)
88. V.D. Peltekova, R.F. Wintle, L.A. Rubin, C.I. Amos, Q. Huang, and X. Gu Functional variants of OCTN cation transporter genes are associated with Crohn disease Nat Genet 36 2004 471 475 (Pubitemid 38620030)
89. S. Purcet, G. Minuesa, M. Molina-Arcas, I. Erkizia, F.J. Casado, and B. Clotet 3'-Azido-2',3'-dideoxythymidine (zidovudine) uptake mechanisms in T lymphocytes Antivir Ther 11 2006 803 811 (Pubitemid 44497176)
90. A.S. Ray, T. Cihlar, K.L. Robinson, L. Tong, J.E. Vela, and M.D. Fuller Mechanism of active renal tubular efflux of tenofovir Antimicrob Agents Chemother 50 2006 3297 3304 (Pubitemid 44527501)
91. M.W. Ritzel, S.Y. Yao, M.Y. Huang, J.F. Elliott, C.E. Cass, and J.D. Young Molecular cloning and functional expression of cDNAs encoding a human Na+-nucleoside cotransporter (hCNT1) Am J Physiol 272 1997 C707 C714
92. M.W. Ritzel, A.M. Ng, S.Y. Yao, K. Graham, S.K. Loewen, and K.M. Smith Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib) J Biol Chem 276 2001 2914 2927
93. P.T. Ronaldson, Y. Persidsky, and R. Bendayan Regulation of ABC membrane transporters in glial cells: relevance to the pharmacotherapy of brain HIV-1 infection Glia 56 2008 1711 1735
94. I. Rubio-Aliaga, and H. Daniel Peptide transporters and their roles in physiological processes and drug disposition Xenobiotica 38 2008 1022 1042
95. E. Schneider, F. Machavoine, J.M. Pleau, A.F. Bertron, R.L. Thurmond, and H. Ohtsu Organic cation transporter 3 modulates murine basophil functions by controlling intracellular histamine levels J Exp Med 202 2005 387 393 (Pubitemid 41126956)
96. T. Sekine, S.H. Cha, M. Tsuda, N. Apiwattanakul, N. Nakajima, and Y. Kanai Identification of multispecific organic anion transporter 2 expressed predominantly in the liver FEBS Lett 429 1998 179 182 (Pubitemid 28288205)
97. H.J. Shin, N. Anzai, A. Enomoto, X. He, K. Kim do, and H. Endou Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate Hepatology 45 2007 1046 1055 (Pubitemid 46631573)
98. Y. Shu, S.A. Sheardown, C. Brown, R.P. Owen, S. Zhang, and R.A. Castro Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action J Clin Invest 117 2007 1422 1431 (Pubitemid 46718430)
99. Y. Shu, C. Brown, R.A. Castro, R.J. Shi, E.T. Lin, and R.P. Owen Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics Clin Pharmacol Ther 83 2008 273 280
100. S. Shugarts, and L.Z. Benet The role of transporters in the pharmacokinetics of orally administered drugs Pharm Res 26 2009 2039 2054
101. M. Siccardi, A. D'Avolio, S. Nozza, M. Simiele, L. Baietto, and F.R. Stefani Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism Pharmacogenet Genomics 20 2010 759 765
102. M. Siccardi, A. D'Avolio, L. Baietto, M. Simiele, S. Bonora, and D. Back Intracellular pharmacokinetics of Atazanavir-Ritonavir (300 mg/100 mg) is influenced by solute carrier organic anion transporter (SLCO) 3A1 expression 18th Conference on Retroviral and Opportunistic Infections (CROI) 2011 http://www.retroconference.org/2011/Abstracts/40262.htm [Abstract #639]
103. G.D. Simonson, A.C. Vincent, K.J. Roberg, Y. Huang, and V. Iwanij Molecular cloning and characterization of a novel liver-specific transport protein J Cell Sci 107 Pt 4 1994 1065 1072
104. C. Skazik, R. Heise, O. Bostanci, N. Paul, B. Denecke, and S. Joussen Differential expression of influx and efflux transport proteins in human antigen presenting cells Exp Dermatol 17 2008 739 747
105. K.M. Smith, A.M. Ng, S.Y. Yao, K.A. Labedz, E.E. Knaus, and L.I. Wiebe Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes J Physiol 558 2004 807 823 (Pubitemid 39199106)
106. K.M. Smith, M.D. Slugoski, S.K. Loewen, A.M. Ng, S.Y. Yao, and X.Z. Chen The broadly selective human Na+/nucleoside cotransporter (hCNT3) exhibits novel cation-coupled nucleoside transport characteristics J Biol Chem 280 2005 25436 25449 (Pubitemid 40962248)
107. C. Srimaroeng, J.L. Perry, and J.B. Pritchard Physiology, structure, and regulation of the cloned organic anion transporters Xenobiotica 38 2008 889 935
108. N. Strazielle, M.F. Belin, and J.F. Ghersi-Egea Choroid plexus controls brain availability of anti-HIV nucleoside analogs via pharmacologically inhibitable organic anion transporters AIDS 17 2003 1473 1485 (Pubitemid 36900548)
109. Y. Su, X. Zhang, and P.J. Sinko Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells Mol Pharm 1 2004 49 56
110. M. Takeda, S. Khamdang, S. Narikawa, H. Kimura, Y. Kobayashi, and T. Yamamoto Human organic anion transporters and human organic cation transporters mediate renal antiviral transport J Pharmacol Exp Ther 300 2002 918 924 (Pubitemid 34164996)
111. I. Tamai, J. Nezu, H. Uchino, Y. Sai, A. Oku, and M. Shimane Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family Biochem Biophys Res Commun 273 2000 251 260 (Pubitemid 30426895)
112. R.G. Tirona, B.F. Leake, A.W. Wolkoff, and R.B. Kim Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation J Pharmacol Exp Ther 304 2003 223 228 (Pubitemid 36008932)
113. S. Tokuhiro, R. Yamada, X. Chang, A. Suzuki, Y. Kochi, and T. Sawada An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis Nat Genet 35 2003 341 348 (Pubitemid 37486917)
114. O. Turriziani, and G. Antonelli Host factors and efficacy of antiretroviral treatment New Microbiol 27 2004 63 69 (Pubitemid 40090991)
115. Y. Uwai, H. Ida, Y. Tsuji, T. Katsura, and K. Inui Renal transport of adefovir, cidofovir, and tenofovir by SLC22A family members (hOAT1, hOAT3, and hOCT2) Pharm Res 24 2007 811 815 (Pubitemid 46411965)
116. A.L. VanWert, M.R. Gionfriddo, and D.H. Sweet Organic anion transporters: discovery, pharmacology, regulation and roles in pathophysiology Biopharm Drug Dispos 31 2010 1 71
117. L. Varatharajan, and S.A. Thomas The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research Antiviral Res 82 2009 A99 A109
118. U.A. Walker, B. Setzer, and N. Venhoff Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors AIDS 16 2002 2165 2173 (Pubitemid 35387271)
119. L.A. Wenning, E.J. Friedman, J.T. Kost, S.A. Breidinger, J.E. Stek, and K.C. Lasseter Lack of a significant drug interaction between raltegravir and tenofovir Antimicrob Agents Chemother 52 2008 3253 3258
120. S.H. Wright, and W.H. Dantzler Molecular and cellular physiology of renal organic cation and anion transport Physiol Rev 84 2004 987 1049 (Pubitemid 38823772)
121. H.E. Wynn, R.C. Brundage, and C.V. Fletcher Clinical implications of CNS penetration of antiretroviral drugs CNS Drugs 16 2002 595 609
122. S.Y. Yao, A.M. Ng, M. Sundaram, C.E. Cass, S.A. Baldwin, and J.D. Young Transport of antiviral 3'-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes Mol Membr Biol 18 2001 161 167 (Pubitemid 32666795)
123. Z.W. Ye, J. Van Pelt, S. Camus, J. Snoeys, P. Augustijns, and P. Annaert Species-specific interaction of HIV protease inhibitors with accumulation of cholyl-glycylamido-fluorescein (CGamF) in sandwich-cultured hepatocytes J Pharm Sci 99 2010 2886 2898
124. Z.M. Zair, J.J. Eloranta, B. Stieger, and G.A. Kullak-Ublick Pharmacogenetics of OATP (SLC21/SLCO), OAT and OCT (SLC22) and PEPT (SLC15) transporters in the intestine, liver and kidney Pharmacogenomics 9 2008 597 624 (Pubitemid 351803919)
125. L. Zhang, W. Gorset, C.B. Washington, T.F. Blaschke, D.L. Kroetz, and K.M. Giacomini Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system Drug Metab Dispos 28 2000 329 334 (Pubitemid 30137058)
126. T.P. Zimmerman, W.B. Mahony, and K.L. Prus 3'-azido-3'-deoxythymidine J Biol Chem 262 1987 5748 5754